Table 6 Multivariate analysis of factors associated with neurological involvement in primary and secondary Sjögren’s syndrome
From: Clinical features and risk factors of neurological involvement in Sjögren’s syndrome
Independent variables | Multivariate analysis OR (95% CI) P value | |
|---|---|---|
pSS | sSS | |
Age < 50 | ||
Sex (male) | 4.56 (1.15, 20.01) 0.013 | |
Low C3 level (< 0.9 g/L) | 2.21 (1.04, 4.82) 0.026 | 3.33 (1.92, 8.03) 0.021 |
Xerophthalmia, n (%) | 3.03 (1.08, 7.45) 0.030 | |
Age >= 50 | ||
ANA positivity | 5.52(1.42, 37.28) 0.037 | |
Cardiac involvement | 2.38 (1.18, 5.06) 0.013 | |
Saliva gland atrophy | 0.28 (0.13, 0.59) 0.001 | |
Xerophthalmia, n (%) | 4.07 (1.25, 14.35)0.012 | |